 Robert Batey
Concepts (495)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Riboswitch | 39 | 2025 | 63 | 14.900 |
Why?
| | RNA, Bacterial | 30 | 2025 | 189 | 6.550 |
Why?
| | Nucleic Acid Conformation | 65 | 2025 | 726 | 6.510 |
Why?
| | RNA | 36 | 2026 | 940 | 5.960 |
Why?
| | Aptamers, Nucleotide | 25 | 2025 | 85 | 4.600 |
Why?
| | Ligands | 36 | 2025 | 674 | 3.600 |
Why?
| | Models, Molecular | 42 | 2025 | 1619 | 3.230 |
Why?
| | Vitamin B 12 | 8 | 2025 | 127 | 3.090 |
Why?
| | Bacillus subtilis | 13 | 2025 | 69 | 2.920 |
Why?
| | Gene Expression Regulation, Bacterial | 12 | 2025 | 328 | 2.880 |
Why?
| | RNA Folding | 8 | 2023 | 35 | 2.770 |
Why?
| | Crystallography, X-Ray | 29 | 2025 | 493 | 2.650 |
Why?
| | S-Adenosylmethionine | 12 | 2017 | 59 | 2.550 |
Why?
| | Base Sequence | 40 | 2023 | 2191 | 2.480 |
Why?
| | Purines | 11 | 2019 | 187 | 2.440 |
Why?
| | RNA, Messenger | 19 | 2024 | 2832 | 2.290 |
Why?
| | Binding Sites | 32 | 2025 | 1331 | 2.090 |
Why?
| | 5' Untranslated Regions | 10 | 2014 | 59 | 2.060 |
Why?
| | Bacterial Proteins | 10 | 2025 | 962 | 1.800 |
Why?
| | Transcription, Genetic | 11 | 2020 | 1496 | 1.580 |
Why?
| | Small Molecule Libraries | 3 | 2025 | 111 | 1.520 |
Why?
| | Gene Expression Regulation | 13 | 2020 | 2609 | 1.430 |
Why?
| | RNA, Catalytic | 9 | 2024 | 189 | 1.270 |
Why?
| | Protein Binding | 18 | 2025 | 2276 | 1.270 |
Why?
| | Drug Design | 3 | 2025 | 173 | 1.190 |
Why?
| | Molecular Sequence Data | 25 | 2015 | 2931 | 1.160 |
Why?
| | Adenine | 7 | 2020 | 339 | 1.130 |
Why?
| | Regulatory Sequences, Ribonucleic Acid | 6 | 2007 | 18 | 1.100 |
Why?
| | Fluorescent Dyes | 3 | 2025 | 330 | 1.050 |
Why?
| | Biosensing Techniques | 2 | 2020 | 139 | 1.010 |
Why?
| | Flavin Mononucleotide | 3 | 2025 | 8 | 0.980 |
Why?
| | rhoB GTP-Binding Protein | 1 | 2025 | 4 | 0.920 |
Why?
| | Rhodamines | 1 | 2025 | 21 | 0.910 |
Why?
| | Deoxyguanosine | 2 | 2019 | 25 | 0.900 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein U | 2 | 2024 | 7 | 0.880 |
Why?
| | Tetrahydrofolates | 3 | 2015 | 16 | 0.870 |
Why?
| | Bacteria | 5 | 2024 | 889 | 0.870 |
Why?
| | Genetic Engineering | 3 | 2014 | 93 | 0.850 |
Why?
| | Escherichia coli | 10 | 2020 | 855 | 0.830 |
Why?
| | Biochemical Phenomena | 1 | 2023 | 9 | 0.790 |
Why?
| | Introns | 4 | 2014 | 254 | 0.780 |
Why?
| | Guanine | 6 | 2011 | 87 | 0.770 |
Why?
| | HMGB Proteins | 1 | 2023 | 17 | 0.760 |
Why?
| | Signal Recognition Particle | 6 | 2007 | 9 | 0.750 |
Why?
| | RNA-Binding Proteins | 7 | 2025 | 464 | 0.730 |
Why?
| | Base Pairing | 12 | 2020 | 65 | 0.710 |
Why?
| | CRISPR-Cas Systems | 2 | 2020 | 170 | 0.700 |
Why?
| | Models, Genetic | 3 | 2020 | 536 | 0.680 |
Why?
| | Anti-Infective Agents | 1 | 2024 | 242 | 0.670 |
Why?
| | Escherichia coli K12 | 1 | 2020 | 8 | 0.670 |
Why?
| | CRISPR-Associated Proteins | 1 | 2020 | 3 | 0.660 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2020 | 16 | 0.660 |
Why?
| | Enzyme Assays | 1 | 2020 | 25 | 0.650 |
Why?
| | Ribosomal Proteins | 6 | 2006 | 91 | 0.640 |
Why?
| | Magnesium | 8 | 2015 | 155 | 0.640 |
Why?
| | Chromatography, Affinity | 3 | 2009 | 85 | 0.630 |
Why?
| | Lysine | 3 | 2012 | 302 | 0.620 |
Why?
| | Endodeoxyribonucleases | 1 | 2020 | 78 | 0.620 |
Why?
| | Protein Biosynthesis | 3 | 2016 | 458 | 0.620 |
Why?
| | Thermodynamics | 12 | 2014 | 426 | 0.610 |
Why?
| | SOXB1 Transcription Factors | 1 | 2020 | 67 | 0.600 |
Why?
| | Gene Editing | 1 | 2020 | 93 | 0.580 |
Why?
| | RNA, Long Noncoding | 4 | 2022 | 178 | 0.560 |
Why?
| | Quinoxalines | 1 | 2018 | 65 | 0.550 |
Why?
| | Crystallization | 7 | 2019 | 146 | 0.530 |
Why?
| | Archaeal Proteins | 2 | 2009 | 49 | 0.530 |
Why?
| | Drugs, Chinese Herbal | 4 | 2017 | 24 | 0.520 |
Why?
| | Dihydroxyphenylalanine | 1 | 2017 | 11 | 0.510 |
Why?
| | 5-Hydroxytryptophan | 1 | 2017 | 19 | 0.510 |
Why?
| | Cobamides | 1 | 2017 | 25 | 0.510 |
Why?
| | Synthetic Biology | 2 | 2014 | 15 | 0.490 |
Why?
| | Receptors, Glucocorticoid | 3 | 2023 | 138 | 0.490 |
Why?
| | Cyanobacteria | 1 | 2017 | 55 | 0.490 |
Why?
| | Ribosomes | 3 | 2006 | 191 | 0.490 |
Why?
| | Kinetics | 9 | 2017 | 1629 | 0.480 |
Why?
| | Coenzymes | 1 | 2016 | 19 | 0.480 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 442 | 0.470 |
Why?
| | Mutation | 9 | 2017 | 4099 | 0.470 |
Why?
| | Calorimetry | 3 | 2012 | 72 | 0.460 |
Why?
| | X-Ray Diffraction | 1 | 2016 | 104 | 0.460 |
Why?
| | Conserved Sequence | 8 | 2017 | 245 | 0.460 |
Why?
| | DNA | 7 | 2025 | 1464 | 0.440 |
Why?
| | Chemical Fractionation | 1 | 2014 | 28 | 0.420 |
Why?
| | Folic Acid Antagonists | 1 | 2014 | 8 | 0.410 |
Why?
| | Thermotoga maritima | 3 | 2009 | 12 | 0.410 |
Why?
| | S-Adenosylhomocysteine | 2 | 2010 | 24 | 0.400 |
Why?
| | Ribonucleotides | 5 | 2017 | 26 | 0.390 |
Why?
| | Purine Nucleotides | 1 | 2013 | 12 | 0.390 |
Why?
| | Static Electricity | 5 | 2020 | 113 | 0.380 |
Why?
| | Anti-Bacterial Agents | 3 | 2024 | 1915 | 0.370 |
Why?
| | Fluorescence | 3 | 2025 | 161 | 0.360 |
Why?
| | Ribonucleoproteins | 3 | 2020 | 103 | 0.350 |
Why?
| | Streptococcus mutans | 1 | 2011 | 8 | 0.350 |
Why?
| | RNA, Ribosomal | 3 | 2003 | 168 | 0.350 |
Why?
| | Substrate Specificity | 5 | 2018 | 392 | 0.350 |
Why?
| | Molecular Structure | 5 | 2025 | 501 | 0.350 |
Why?
| | Intrinsically Disordered Proteins | 2 | 2024 | 43 | 0.330 |
Why?
| | RNA, Ribosomal, 16S | 4 | 1999 | 559 | 0.330 |
Why?
| | RNA, Archaeal | 2 | 2009 | 11 | 0.320 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 320 | 0.320 |
Why?
| | Mouse Embryonic Stem Cells | 2 | 2020 | 38 | 0.310 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1500 | 0.310 |
Why?
| | Pyrococcus horikoshii | 1 | 2009 | 3 | 0.300 |
Why?
| | Ribonucleoproteins, Small Nuclear | 1 | 2009 | 22 | 0.300 |
Why?
| | Transcription Factors | 5 | 2023 | 1742 | 0.290 |
Why?
| | Geobacillus stearothermophilus | 3 | 1998 | 12 | 0.280 |
Why?
| | Models, Chemical | 3 | 2008 | 269 | 0.280 |
Why?
| | Protein Structure, Secondary | 5 | 2011 | 369 | 0.280 |
Why?
| | Ethanol | 5 | 2000 | 627 | 0.280 |
Why?
| | Genes, Reporter | 2 | 2020 | 276 | 0.280 |
Why?
| | Gene Expression | 5 | 2014 | 1490 | 0.280 |
Why?
| | Fructose | 4 | 2016 | 130 | 0.270 |
Why?
| | Proteobacteria | 1 | 2008 | 16 | 0.270 |
Why?
| | Hydrogen Bonding | 5 | 2012 | 169 | 0.270 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2024 | 87 | 0.270 |
Why?
| | Animals | 28 | 2024 | 38109 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 5 | 2000 | 1217 | 0.260 |
Why?
| | Liver | 6 | 2015 | 1888 | 0.260 |
Why?
| | Genes, Switch | 1 | 2006 | 6 | 0.250 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 4 | 0.250 |
Why?
| | Hepatitis B virus | 2 | 2025 | 33 | 0.250 |
Why?
| | RNA, Small Nucleolar | 1 | 2006 | 8 | 0.250 |
Why?
| | Protein Domains | 4 | 2025 | 313 | 0.250 |
Why?
| | Thermoanaerobacter | 1 | 2006 | 1 | 0.250 |
Why?
| | Aziridines | 1 | 2026 | 6 | 0.240 |
Why?
| | Epoxy Compounds | 1 | 2026 | 32 | 0.240 |
Why?
| | Methyltransferases | 1 | 2006 | 74 | 0.240 |
Why?
| | Pyrimidines | 2 | 2006 | 533 | 0.230 |
Why?
| | SELEX Aptamer Technique | 1 | 2005 | 16 | 0.230 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2006 | 92 | 0.230 |
Why?
| | Protein Structure, Tertiary | 6 | 2009 | 862 | 0.230 |
Why?
| | Amides | 1 | 2026 | 101 | 0.230 |
Why?
| | Telomerase | 1 | 2008 | 248 | 0.230 |
Why?
| | Cobalt | 3 | 2016 | 53 | 0.230 |
Why?
| | Hepatitis B, Chronic | 1 | 2025 | 22 | 0.230 |
Why?
| | Isotope Labeling | 2 | 1996 | 83 | 0.220 |
Why?
| | Binding, Competitive | 3 | 2020 | 193 | 0.220 |
Why?
| | GATA1 Transcription Factor | 1 | 2025 | 18 | 0.220 |
Why?
| | Amino Acid Motifs | 2 | 2024 | 224 | 0.220 |
Why?
| | Mutagenesis | 2 | 2020 | 192 | 0.220 |
Why?
| | Magnetic Resonance Spectroscopy | 5 | 2004 | 631 | 0.220 |
Why?
| | Hypoxanthine | 1 | 2004 | 11 | 0.220 |
Why?
| | RNA-Binding Motifs | 1 | 2024 | 3 | 0.210 |
Why?
| | Fluorescence Polarization | 1 | 2024 | 24 | 0.210 |
Why?
| | Dexamethasone | 2 | 2023 | 372 | 0.210 |
Why?
| | Structure-Activity Relationship | 3 | 2018 | 570 | 0.200 |
Why?
| | Alcohol Dehydrogenase | 2 | 1994 | 16 | 0.200 |
Why?
| | X Chromosome Inactivation | 2 | 2020 | 27 | 0.200 |
Why?
| | Inappropriate Prescribing | 1 | 2024 | 64 | 0.190 |
Why?
| | Escherichia coli Proteins | 3 | 2007 | 206 | 0.190 |
Why?
| | Cations, Monovalent | 1 | 2002 | 6 | 0.190 |
Why?
| | Phylogeny | 4 | 2014 | 1019 | 0.190 |
Why?
| | RNA, Protozoan | 2 | 2004 | 60 | 0.190 |
Why?
| | RNA, Viral | 2 | 2020 | 688 | 0.190 |
Why?
| | Cations, Divalent | 1 | 2002 | 47 | 0.190 |
Why?
| | Fatty Liver | 2 | 2015 | 251 | 0.190 |
Why?
| | Leucovorin | 2 | 2014 | 101 | 0.190 |
Why?
| | Iridium | 2 | 2016 | 7 | 0.190 |
Why?
| | Sequence Deletion | 2 | 2020 | 193 | 0.180 |
Why?
| | Metals | 1 | 2002 | 142 | 0.170 |
Why?
| | Sheep | 1 | 2024 | 880 | 0.170 |
Why?
| | Estrogen Receptor alpha | 1 | 2022 | 161 | 0.170 |
Why?
| | Leptotrichia | 1 | 2020 | 1 | 0.170 |
Why?
| | Cations | 3 | 2016 | 82 | 0.170 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2020 | 5 | 0.160 |
Why?
| | Molecular Conformation | 3 | 2014 | 148 | 0.160 |
Why?
| | Terminator Regions, Genetic | 2 | 2011 | 13 | 0.160 |
Why?
| | Rats, Wistar | 8 | 2000 | 451 | 0.160 |
Why?
| | Liver Diseases, Alcoholic | 2 | 2000 | 97 | 0.160 |
Why?
| | Hepatitis, Animal | 1 | 2000 | 2 | 0.160 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 36 | 0.160 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1371 | 0.160 |
Why?
| | X Chromosome | 1 | 2020 | 67 | 0.160 |
Why?
| | Rifampin | 1 | 2020 | 82 | 0.160 |
Why?
| | Helicobacter pylori | 4 | 2001 | 45 | 0.160 |
Why?
| | Theophylline | 1 | 2020 | 41 | 0.160 |
Why?
| | Gram-Negative Aerobic Bacteria | 2 | 1996 | 5 | 0.150 |
Why?
| | Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2020 | 35 | 0.150 |
Why?
| | Computational Biology | 1 | 2024 | 681 | 0.150 |
Why?
| | Endogenous Retroviruses | 1 | 2020 | 38 | 0.150 |
Why?
| | Liver Cirrhosis, Alcoholic | 2 | 1998 | 19 | 0.150 |
Why?
| | Nitrogen Isotopes | 2 | 1996 | 72 | 0.150 |
Why?
| | Point Mutation | 2 | 2011 | 243 | 0.150 |
Why?
| | Aminoimidazole Carboxamide | 2 | 2017 | 12 | 0.150 |
Why?
| | Cloning, Molecular | 1 | 2020 | 541 | 0.150 |
Why?
| | Evolution, Molecular | 3 | 2014 | 515 | 0.140 |
Why?
| | Rats | 11 | 2016 | 5614 | 0.140 |
Why?
| | Carbon Isotopes | 2 | 1996 | 144 | 0.140 |
Why?
| | Humans | 28 | 2025 | 144957 | 0.140 |
Why?
| | Models, Biological | 4 | 2017 | 1822 | 0.140 |
Why?
| | Tetrahymena thermophila | 3 | 2004 | 68 | 0.140 |
Why?
| | Genes, Bacterial | 3 | 2009 | 166 | 0.130 |
Why?
| | 2-Aminopurine | 2 | 2009 | 8 | 0.130 |
Why?
| | Polymerase Chain Reaction | 4 | 2009 | 1054 | 0.130 |
Why?
| | Insulin Resistance | 2 | 2016 | 1241 | 0.130 |
Why?
| | Hyperprolactinemia | 1 | 2017 | 6 | 0.130 |
Why?
| | Aquatic Organisms | 1 | 2017 | 10 | 0.130 |
Why?
| | Monoterpenes | 1 | 2017 | 16 | 0.130 |
Why?
| | Flavanones | 1 | 2017 | 7 | 0.130 |
Why?
| | Endotoxemia | 1 | 1998 | 87 | 0.130 |
Why?
| | Prolactin | 1 | 2017 | 89 | 0.130 |
Why?
| | Glucosides | 1 | 2017 | 55 | 0.120 |
Why?
| | T-Lymphocytes | 6 | 2001 | 1982 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2018 | 418 | 0.120 |
Why?
| | Transcriptome | 1 | 2023 | 1046 | 0.120 |
Why?
| | Glucose Transporter Type 4 | 1 | 2016 | 38 | 0.120 |
Why?
| | Sarcolemma | 1 | 2016 | 38 | 0.120 |
Why?
| | Temperature | 3 | 2008 | 679 | 0.120 |
Why?
| | Deuterium | 1 | 1996 | 100 | 0.120 |
Why?
| | Affinity Labels | 2 | 2007 | 25 | 0.120 |
Why?
| | Salts | 1 | 2016 | 37 | 0.120 |
Why?
| | Xanthones | 1 | 2015 | 6 | 0.120 |
Why?
| | MicroRNAs | 1 | 2022 | 701 | 0.120 |
Why?
| | Species Specificity | 1 | 2017 | 574 | 0.120 |
Why?
| | CD36 Antigens | 1 | 2015 | 32 | 0.120 |
Why?
| | Nucleotides | 1 | 1996 | 128 | 0.120 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 82 | 0.120 |
Why?
| | Diacylglycerol O-Acyltransferase | 1 | 2015 | 5 | 0.110 |
Why?
| | Genetic Variation | 1 | 2020 | 984 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2009 | 561 | 0.110 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2015 | 55 | 0.110 |
Why?
| | Viral Proteins | 3 | 2009 | 355 | 0.110 |
Why?
| | CD4-Positive T-Lymphocytes | 3 | 2000 | 1129 | 0.110 |
Why?
| | Monocytes | 1 | 1998 | 538 | 0.110 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2014 | 157 | 0.110 |
Why?
| | Gastrostomy | 1 | 1996 | 130 | 0.110 |
Why?
| | Protein Engineering | 1 | 2016 | 122 | 0.110 |
Why?
| | Interleukin-1 | 2 | 1998 | 961 | 0.110 |
Why?
| | Protein Conformation | 3 | 2004 | 946 | 0.110 |
Why?
| | Hydroxocobalamin | 1 | 2014 | 33 | 0.110 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 1995 | 139 | 0.100 |
Why?
| | Transcription Termination, Genetic | 1 | 2014 | 23 | 0.100 |
Why?
| | Molecular Docking Simulation | 1 | 2014 | 124 | 0.100 |
Why?
| | Plasmids | 2 | 2018 | 379 | 0.100 |
Why?
| | RNA Stability | 1 | 2014 | 119 | 0.100 |
Why?
| | Concanavalin A | 4 | 2000 | 71 | 0.090 |
Why?
| | Hepatitis B | 1 | 1993 | 66 | 0.090 |
Why?
| | RNA, Transfer | 1 | 2014 | 144 | 0.090 |
Why?
| | HIV Long Terminal Repeat | 1 | 1992 | 11 | 0.090 |
Why?
| | Cytoplasm | 1 | 1993 | 269 | 0.090 |
Why?
| | Methotrexate | 1 | 2014 | 240 | 0.090 |
Why?
| | Dietary Carbohydrates | 1 | 1993 | 151 | 0.090 |
Why?
| | Cytoskeleton | 1 | 1993 | 195 | 0.090 |
Why?
| | Guanosine Triphosphate | 2 | 2004 | 89 | 0.090 |
Why?
| | Metabolic Syndrome | 1 | 2015 | 354 | 0.090 |
Why?
| | Operator Regions, Genetic | 1 | 1991 | 8 | 0.090 |
Why?
| | Fusobacterium nucleatum | 1 | 2011 | 4 | 0.090 |
Why?
| | Interleukin-6 | 4 | 2000 | 780 | 0.090 |
Why?
| | Potassium Chloride | 1 | 1991 | 40 | 0.090 |
Why?
| | Drug Discovery | 1 | 2012 | 155 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2009 | 2157 | 0.080 |
Why?
| | Hepatitis B Surface Antigens | 2 | 2025 | 17 | 0.080 |
Why?
| | Potassium | 2 | 2002 | 152 | 0.080 |
Why?
| | Bacteriophage lambda | 1 | 1991 | 90 | 0.080 |
Why?
| | Mice | 5 | 2020 | 18365 | 0.080 |
Why?
| | Crystallography | 1 | 2010 | 28 | 0.080 |
Why?
| | Scattering, Small Angle | 1 | 2010 | 26 | 0.080 |
Why?
| | Alcohol Drinking | 2 | 1995 | 826 | 0.080 |
Why?
| | Duodenum | 3 | 1996 | 77 | 0.080 |
Why?
| | Folic Acid | 1 | 2011 | 199 | 0.080 |
Why?
| | Replication Protein A | 1 | 2009 | 14 | 0.080 |
Why?
| | Adenosine | 2 | 2009 | 255 | 0.080 |
Why?
| | Clostridium botulinum | 1 | 2009 | 4 | 0.080 |
Why?
| | Central Nervous System Depressants | 2 | 2000 | 83 | 0.070 |
Why?
| | Gastritis | 2 | 2000 | 115 | 0.070 |
Why?
| | DNA, Viral | 1 | 1991 | 358 | 0.070 |
Why?
| | Titrimetry | 1 | 2009 | 12 | 0.070 |
Why?
| | Nucleic Acid Denaturation | 1 | 2009 | 32 | 0.070 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 331 | 0.070 |
Why?
| | Glucocorticoids | 2 | 2023 | 535 | 0.070 |
Why?
| | Open Reading Frames | 1 | 2009 | 132 | 0.070 |
Why?
| | 3' Untranslated Regions | 1 | 2009 | 152 | 0.070 |
Why?
| | Schizosaccharomyces pombe Proteins | 1 | 2009 | 76 | 0.070 |
Why?
| | Protein Interaction Mapping | 1 | 2009 | 105 | 0.070 |
Why?
| | Muscle, Skeletal | 2 | 2016 | 1796 | 0.070 |
Why?
| | DNA, Bacterial | 2 | 2008 | 342 | 0.070 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2009 | 63 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2009 | 368 | 0.070 |
Why?
| | Lipopolysaccharides | 4 | 2000 | 863 | 0.070 |
Why?
| | ortho-Aminobenzoates | 1 | 2008 | 10 | 0.070 |
Why?
| | Exons | 1 | 2009 | 358 | 0.070 |
Why?
| | Anhydrides | 1 | 2008 | 19 | 0.070 |
Why?
| | Telomere-Binding Proteins | 1 | 2009 | 119 | 0.070 |
Why?
| | Female | 22 | 2025 | 78376 | 0.070 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 409 | 0.070 |
Why?
| | Repressor Proteins | 1 | 1991 | 437 | 0.070 |
Why?
| | History, 21st Century | 1 | 2008 | 219 | 0.060 |
Why?
| | Nucleic Acids | 1 | 2008 | 72 | 0.060 |
Why?
| | Base Pair Mismatch | 1 | 2006 | 10 | 0.060 |
Why?
| | Male | 12 | 2025 | 72406 | 0.060 |
Why?
| | Interleukin-2 | 2 | 2001 | 437 | 0.060 |
Why?
| | Azoarcus | 1 | 2006 | 1 | 0.060 |
Why?
| | History, 20th Century | 1 | 2008 | 325 | 0.060 |
Why?
| | Helicobacter Infections | 3 | 2001 | 30 | 0.060 |
Why?
| | Telomere | 1 | 2009 | 288 | 0.060 |
Why?
| | Thiamine Pyrophosphate | 1 | 2006 | 4 | 0.060 |
Why?
| | Stereoisomerism | 1 | 2026 | 105 | 0.060 |
Why?
| | Methylation | 1 | 2006 | 242 | 0.060 |
Why?
| | Sulfur | 1 | 2006 | 64 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1389 | 0.060 |
Why?
| | Hepatitis B e Antigens | 1 | 2025 | 3 | 0.060 |
Why?
| | Northern Territory | 1 | 2025 | 4 | 0.060 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2009 | 419 | 0.060 |
Why?
| | Methionine | 1 | 2006 | 162 | 0.060 |
Why?
| | Alternative Splicing | 1 | 2008 | 249 | 0.060 |
Why?
| | Cell Cycle Proteins | 1 | 2009 | 629 | 0.060 |
Why?
| | HEK293 Cells | 2 | 2018 | 744 | 0.060 |
Why?
| | Alanine Transaminase | 3 | 2000 | 151 | 0.060 |
Why?
| | Operon | 1 | 2004 | 69 | 0.050 |
Why?
| | Methanococcus | 1 | 2004 | 8 | 0.050 |
Why?
| | Time Factors | 3 | 2009 | 7183 | 0.050 |
Why?
| | Microscopy, Electron | 2 | 1995 | 415 | 0.050 |
Why?
| | Lymphocyte Activation | 2 | 1998 | 1126 | 0.050 |
Why?
| | Membrane Transport Proteins | 1 | 2004 | 154 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2025 | 288 | 0.050 |
Why?
| | Cesium | 1 | 2002 | 20 | 0.050 |
Why?
| | Energy Transfer | 1 | 2002 | 49 | 0.050 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2014 | 178 | 0.050 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 210 | 0.040 |
Why?
| | Enterocytes | 1 | 2001 | 16 | 0.040 |
Why?
| | Interferon-gamma | 3 | 2001 | 784 | 0.040 |
Why?
| | Ferritins | 1 | 2021 | 69 | 0.040 |
Why?
| | Antigens, Bacterial | 2 | 2000 | 127 | 0.040 |
Why?
| | Cell Membrane Permeability | 1 | 2001 | 85 | 0.040 |
Why?
| | Body Weight | 2 | 2016 | 978 | 0.040 |
Why?
| | Ferric Compounds | 1 | 2021 | 55 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 851 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 383 | 0.040 |
Why?
| | RNA, Untranslated | 1 | 2022 | 124 | 0.040 |
Why?
| | Endopeptidases | 1 | 2001 | 82 | 0.040 |
Why?
| | Australia | 1 | 2021 | 286 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2001 | 143 | 0.040 |
Why?
| | RNA Splicing | 1 | 2022 | 285 | 0.040 |
Why?
| | Dosage Compensation, Genetic | 1 | 2020 | 11 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2017 | 2540 | 0.040 |
Why?
| | Transformation, Bacterial | 1 | 2000 | 9 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1835 | 0.040 |
Why?
| | Hepatitis, Alcoholic | 1 | 1999 | 16 | 0.040 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 3550 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2025 | 768 | 0.040 |
Why?
| | Stomach Neoplasms | 1 | 2001 | 128 | 0.040 |
Why?
| | Iron | 1 | 2021 | 359 | 0.040 |
Why?
| | Chromatin | 1 | 2023 | 561 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5872 | 0.040 |
Why?
| | RNA, Small Nuclear | 1 | 2018 | 38 | 0.030 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 1998 | 10 | 0.030 |
Why?
| | Color | 1 | 2018 | 81 | 0.030 |
Why?
| | Middle Aged | 9 | 2025 | 35928 | 0.030 |
Why?
| | Kupffer Cells | 1 | 1998 | 53 | 0.030 |
Why?
| | Tetrahymena | 1 | 1998 | 158 | 0.030 |
Why?
| | Renal Dialysis | 1 | 2021 | 462 | 0.030 |
Why?
| | RNA-Binding Protein FUS | 1 | 2017 | 15 | 0.030 |
Why?
| | Prolactinoma | 1 | 2017 | 13 | 0.030 |
Why?
| | Disease Progression | 1 | 2025 | 2852 | 0.030 |
Why?
| | Metoclopramide | 1 | 2017 | 19 | 0.030 |
Why?
| | G-Quadruplexes | 1 | 2017 | 25 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2020 | 619 | 0.030 |
Why?
| | Dinucleoside Phosphates | 1 | 2017 | 31 | 0.030 |
Why?
| | Cell Line | 2 | 2020 | 2882 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 371 | 0.030 |
Why?
| | Diethyl Pyrocarbonate | 1 | 1996 | 3 | 0.030 |
Why?
| | Glycosides | 1 | 2017 | 42 | 0.030 |
Why?
| | Ethylnitrosourea | 1 | 1996 | 13 | 0.030 |
Why?
| | Gastroscopy | 1 | 1996 | 18 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2018 | 405 | 0.030 |
Why?
| | Thionucleotides | 1 | 1996 | 35 | 0.030 |
Why?
| | Protein Folding | 1 | 1998 | 279 | 0.030 |
Why?
| | HeLa Cells | 1 | 2018 | 650 | 0.030 |
Why?
| | Oligoribonucleotides | 1 | 1996 | 52 | 0.030 |
Why?
| | Iodine | 1 | 1996 | 26 | 0.030 |
Why?
| | Water | 1 | 2000 | 469 | 0.030 |
Why?
| | Glutamine | 1 | 2017 | 109 | 0.030 |
Why?
| | Hydrazines | 1 | 1996 | 37 | 0.030 |
Why?
| | Endoribonucleases | 1 | 2017 | 80 | 0.030 |
Why?
| | New South Wales | 2 | 1993 | 21 | 0.030 |
Why?
| | Cell Membrane | 1 | 2000 | 706 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 1998 | 346 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2015 | 37 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2015 | 37 | 0.030 |
Why?
| | Aged | 6 | 2025 | 25947 | 0.030 |
Why?
| | Mutagenesis, Site-Directed | 1 | 1996 | 381 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 341 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1996 | 129 | 0.030 |
Why?
| | Pituitary Neoplasms | 1 | 2017 | 190 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1721 | 0.030 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1996 | 235 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 1995 | 20 | 0.030 |
Why?
| | Response Elements | 1 | 2015 | 89 | 0.030 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2015 | 158 | 0.030 |
Why?
| | Culture Media | 1 | 1995 | 161 | 0.030 |
Why?
| | Hydrolysis | 1 | 1995 | 199 | 0.030 |
Why?
| | Craniocerebral Trauma | 1 | 1996 | 176 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 361 | 0.030 |
Why?
| | Organ Size | 1 | 2015 | 463 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1996 | 216 | 0.030 |
Why?
| | Tissue Embedding | 1 | 1993 | 4 | 0.030 |
Why?
| | Hepatitis B Core Antigens | 1 | 1993 | 2 | 0.030 |
Why?
| | Hepatitis B Antibodies | 1 | 1993 | 6 | 0.030 |
Why?
| | Adult | 8 | 2025 | 40506 | 0.030 |
Why?
| | Killer Cells, Lymphokine-Activated | 1 | 1993 | 12 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2001 | 931 | 0.020 |
Why?
| | Glucose Solution, Hypertonic | 1 | 1993 | 1 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1996 | 284 | 0.020 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 100 | 0.020 |
Why?
| | Urban Health | 1 | 1993 | 96 | 0.020 |
Why?
| | Triglycerides | 1 | 2015 | 521 | 0.020 |
Why?
| | Surgical Wound Infection | 1 | 1996 | 316 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2025 | 17101 | 0.020 |
Why?
| | Injections, Intraperitoneal | 1 | 1993 | 117 | 0.020 |
Why?
| | Seroepidemiologic Studies | 1 | 1993 | 172 | 0.020 |
Why?
| | Metabolic Clearance Rate | 1 | 1993 | 115 | 0.020 |
Why?
| | Cell Division | 3 | 2001 | 766 | 0.020 |
Why?
| | Methylococcaceae | 1 | 1992 | 2 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1995 | 598 | 0.020 |
Why?
| | Aged, 80 and over | 4 | 2001 | 8279 | 0.020 |
Why?
| | Cytokines | 3 | 1996 | 2065 | 0.020 |
Why?
| | Autoradiography | 1 | 1991 | 65 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 1991 | 27 | 0.020 |
Why?
| | DNA Fingerprinting | 1 | 1991 | 32 | 0.020 |
Why?
| | Electrochemistry | 1 | 1991 | 74 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2015 | 653 | 0.020 |
Why?
| | Prospective Studies | 2 | 2021 | 7997 | 0.020 |
Why?
| | Antigens, CD | 1 | 1993 | 555 | 0.020 |
Why?
| | Interleukin-4 | 2 | 2001 | 206 | 0.020 |
Why?
| | Urease | 2 | 2000 | 13 | 0.020 |
Why?
| | Interleukin-8 | 2 | 2001 | 271 | 0.020 |
Why?
| | Immunoglobulin A | 2 | 2001 | 214 | 0.020 |
Why?
| | Chloride Channels | 2 | 2001 | 34 | 0.020 |
Why?
| | Heroin Dependence | 1 | 1989 | 33 | 0.020 |
Why?
| | Case-Control Studies | 1 | 1996 | 3608 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 1993 | 655 | 0.020 |
Why?
| | Lymphocyte Count | 2 | 1998 | 164 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 14126 | 0.020 |
Why?
| | Phosphorylation | 1 | 1992 | 1733 | 0.020 |
Why?
| | Methadone | 1 | 1989 | 122 | 0.020 |
Why?
| | Computer Simulation | 1 | 2011 | 1026 | 0.020 |
Why?
| | Immunoglobulin G | 2 | 2001 | 893 | 0.020 |
Why?
| | Prevalence | 1 | 1993 | 2836 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1995 | 4569 | 0.010 |
Why?
| | Ambulatory Care | 1 | 1989 | 603 | 0.010 |
Why?
| | Pregnancy Complications | 1 | 1989 | 592 | 0.010 |
Why?
| | Immunohistochemistry | 2 | 1998 | 1718 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2001 | 4155 | 0.010 |
Why?
| | Blood Glucose | 1 | 1993 | 2330 | 0.010 |
Why?
| | Xanthine | 1 | 2001 | 7 | 0.010 |
Why?
| | Colforsin | 1 | 2001 | 48 | 0.010 |
Why?
| | Thymidine | 1 | 2001 | 60 | 0.010 |
Why?
| | Mannitol | 1 | 2001 | 40 | 0.010 |
Why?
| | Receptors, Interleukin-2 | 1 | 2001 | 64 | 0.010 |
Why?
| | RNA Probes | 1 | 2001 | 12 | 0.010 |
Why?
| | Hepatitis Delta Virus | 1 | 2001 | 7 | 0.010 |
Why?
| | RNA, Ribosomal, 23S | 1 | 2001 | 12 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1996 | 11695 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2001 | 209 | 0.010 |
Why?
| | Dyspepsia | 1 | 2000 | 10 | 0.010 |
Why?
| | Blood Cells | 1 | 2000 | 37 | 0.010 |
Why?
| | Gastric Mucosa | 1 | 2000 | 52 | 0.010 |
Why?
| | Intestine, Small | 1 | 2001 | 166 | 0.010 |
Why?
| | Antibodies, Bacterial | 1 | 2001 | 148 | 0.010 |
Why?
| | CD4 Antigens | 1 | 2000 | 139 | 0.010 |
Why?
| | Mitogens | 1 | 1999 | 55 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 983 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2001 | 1311 | 0.010 |
Why?
| | Endotoxins | 1 | 1999 | 221 | 0.010 |
Why?
| | Lymphocyte Subsets | 1 | 1998 | 83 | 0.010 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2001 | 370 | 0.010 |
Why?
| | Disaccharidases | 1 | 1996 | 1 | 0.010 |
Why?
| | Ion Transport | 1 | 1996 | 63 | 0.010 |
Why?
| | Immunoblotting | 1 | 1996 | 300 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 76 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 415 | 0.010 |
Why?
| | Keratins | 1 | 1996 | 172 | 0.010 |
Why?
| | Epithelium | 1 | 1996 | 314 | 0.010 |
Why?
| | Cycloheximide | 1 | 1994 | 46 | 0.010 |
Why?
| | DNA Probes | 1 | 1994 | 59 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1813 | 0.010 |
Why?
| | CD56 Antigen | 1 | 1993 | 35 | 0.010 |
Why?
| | Child | 1 | 1993 | 22657 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1993 | 76 | 0.010 |
Why?
| | DNA Primers | 1 | 1994 | 512 | 0.010 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1994 | 161 | 0.010 |
Why?
| | Cell Adhesion Molecules | 1 | 1994 | 178 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1993 | 200 | 0.010 |
Why?
| | CD3 Complex | 1 | 1993 | 111 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2000 | 1524 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1993 | 223 | 0.010 |
Why?
| | Interleukins | 1 | 1994 | 248 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 1994 | 1048 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1998 | 917 | 0.010 |
Why?
| | Apoptosis | 1 | 1999 | 2430 | 0.010 |
Why?
| | Epithelial Cells | 1 | 1996 | 1126 | 0.000 |
Why?
| | Evaluation Studies as Topic | 1 | 1989 | 166 | 0.000 |
Why?
| | Fibroblasts | 1 | 1994 | 1034 | 0.000 |
Why?
| | Intestinal Mucosa | 1 | 1993 | 676 | 0.000 |
Why?
| | Pregnancy | 1 | 1989 | 7191 | 0.000 |
Why?
|
|
Batey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|